Ligand Pharmaceuticals | LGND - Devedores Comerciais





Devedores Comerciais Alterar Data
Agenus USD 22.44M 1.14M 2025-12
Amgen USD 9.14B 432M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
Baxter International USD 1.7B 310M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Enviri Corporation USD 341.34M 27.84M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 178.55M 37.7M 2026-03
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 74M 8M 2026-03
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
MacroGenics USD 13.37M 55.86M 2025-12
Merck USD 11.78B 345M 2025-12
Pacira USD 125.64M 1.57M 2026-03
Pfizer USD 16.17B 332M 2026-03
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 50.11M 5.45M 2026-03